TikTok US-China Deal

by | Sep 16, 2025 | The Doctor's Dose

TikTok US-China Deal: Beijing Confirms Algorithm Use as Trump Extends Deadline TraderInsight • September 2025 • Tech, Social Media, Geopolitics Beijing has confirmed that TikTok’s U.S. app will continue to run on its Chinese-developed algorithm, even as Washington...

Fed Rate Decision and Dot Plot

by | Sep 16, 2025 | The Doctor's Dose

The Federal Reserve heads into this week’s policy meeting with a crowded agenda and a rare layer of political drama. On Wednesday, the FOMC will unveil its policy statement alongside fresh economic projections and the quarterly grid of rate expectations. Markets are...

Fed Rate Cut Trading Strategy

by | Sep 15, 2025 | The Doctor's Dose

Fed Rate Cut Trading Strategy: Stocks and Sectors to Watch The Fed is expected to cut rates by 1.5 percentage points over the next year. But not all cuts are bullish for all stocks. How the 2-year yield reacts will dictate whether traders lean into growth, cyclicals,...

Novo Nordisk Job Cuts

by | Sep 10, 2025 | The Doctor's Dose

Novo Nordisk Job Cuts: 9,000 Roles Axed as Pharma Giant Restructures September 10, 2025 • Healthcare, Pharma, Markets Danish drugmaker Novo Nordisk, maker of the blockbuster weight-loss drug Wegovy, is embarking on a major restructuring under new CEO Maziar Mike...

Lumber Prices Warning Sign

by | Sep 10, 2025 | The Doctor's Dose

Lumber Prices Are Flashing a Warning Sign for the U.S. Economy TraderInsight • September 9, 2025 • Macro, Housing, Materials Lumber futures have fallen roughly a quarter from early August highs, even as major producers announce output cuts. In past cycles, this type...

Biotech Stocks Year-End Rally

by | Sep 9, 2025 | The Doctor's Dose

Biotech’s Breakout: Trading XBI Leaders into Year-End Biotech just put up a statement week: the SPDR S&P Biotech ETF (XBI) gained 6% while the broader healthcare ETF (XLV) slipped ~0.8%. When this corner of the market leads, risk appetite is usually...

Broadcom AI Order

by | Sep 4, 2025 | The Doctor's Dose

Broadcom Beats, Lands a New AI Customer — What It Means for Traders At a Glance Fiscal Q3 Revenue $15.95B (beat) Adj. EPS $1.69 (beat) Q4 Revenue Guide $17.4B (above consensus) AI Revenue Trend +63% YoY to ~$5.2B in Q3; mgmt sees further Q4 growth Stock Action Closed...

CDC Turmoil And Vaccine Stocks

by | Sep 4, 2025 | The Doctor's Dose

CDC Shake-Up Puts Vaccine Trades in Play Washington’s overhaul of the nation’s public-health apparatus is no longer background noise—it’s a live catalyst for vaccine names. This piece explains how CDC turmoil and vaccine stocks intersect with trading tactics you can...

Alphabet Antitrust Ruling

by | Sep 3, 2025 | The Doctor's Dose

Alphabet antitrust ruling sends shares to a record high A federal judge issued targeted remedies in the Google search case—no breakup, no ban on default-search payments—fueling a sharp rally in Alphabet and a relief pop in Apple. Updated September 3, 2025 Alphabet...